These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 7686839)
1. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction. Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction. Zhang YY; Hansson BG; Widell A; Nordenfelt E APMIS; 1992 Sep; 100(9):851-5. PubMed ID: 1382461 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269 [TBL] [Abstract][Full Text] [Related]
4. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA. Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay. Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983 [TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection. Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670 [TBL] [Abstract][Full Text] [Related]
11. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110 [TBL] [Abstract][Full Text] [Related]
12. Testing for HCV markers. Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661 [TBL] [Abstract][Full Text] [Related]
13. [The status and significance of mother-to-infant transmission of hepatitis C virus determined by nested polymerase chain reaction]. Hao F; Li M; Thaler MM; Chen G Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):127-9. PubMed ID: 15619816 [TBL] [Abstract][Full Text] [Related]
14. New-generation RIBA hepatitis C strip immunoblot assays. Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
17. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus. Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993 [TBL] [Abstract][Full Text] [Related]
19. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Farshadpour F; Makvandi M; Samarbafzadeh AR; Jalalifar MA Indian J Med Microbiol; 2010; 28(1):54-6. PubMed ID: 20061766 [TBL] [Abstract][Full Text] [Related]
20. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies]. Tullen E; De Saussure P; Soulier-Lauper M Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]